DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo


6.66 0.02 (0.30%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PDLI $6.66 0.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.62
Previous Close $6.64
Daily Range $6.61 - $6.71
52-Week Range $6.38 - $10.26
Market Cap $1.1B
P/E Ratio 3.46
Dividend (Yield) $0.60 (9.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,337,771
Average Daily Volume 3,573,466
Current FY EPS $2.22




Drug Makers

PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website:

News & Commentary

Why Shares of DepoMed Inc. Sank Today

Shares of the specialty drugmaker DepoMed Inc. fell by double-digits today. Here's why.

Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)

Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC

Asco Preview - The Eloquence Of Elotuzumab

3 Hold-Rated Dividend Stocks: STNG, PBF, PDLI

PDL BioPharma (PDLI) Tops Q1 Earnings, Confirms Guidance - Analyst Blog

PDL BioPharma: Watch Out For The Big Revenue Drop Coming

10 Most Profitable Companies in Healthcare

Like super-profitable companies? These healthcare stocks might be just what the doctor ordered.

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2015 Results - Earnings call Transcript

PDL BioPharma (PDLI) Q1 2015 Results - Earnings Call Webcast

See More PDLI News...

PDLI's Top Competitors

PDLI $6.66 (0.30%)
Current stock: PDLI
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB